Notice of objection to creditor
In accordance with Article 527-5 of the Commercial Act, GeneMatrix Co., Ltd. has entered into a merger agreement with GeneMatrix Bio Co., Ltd.
Since the approval resolution was made by the board of directors held on August 16, 2019, it is announced that there is objection to the merger resolution.
Creditors are requested to submit an objection form within the objection filing period below.
(1) How to file an objection: The objection to the merger must be submitted in writing.
(2) Objection submission period: August 16, 2019 ~ September 16, 2019
(3) Place to submit objections: Submit to GeneMatrix Co., Ltd.
Aug 16th, 2019
GeneMatrix Co., Ltd.
8th floor, B-dong, Korea Bio Park, 700, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do
Kim Soo-ok, CEO of GeneMatrix